Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jonathan S. Leff currently holds 55,150 shares of SUNESIS PHARMACEUTICALS INC (SNSS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jonathan S. Leff has been a net buyer of SNSS stock. They have purchased $107.3M and sold $0 worth of shares.
Jonathan S. Leff's most recent insider trade was on May 19, 2026, when they sold 55,150 shares at $0.00 per share.
Jonathan S. Leff serves as Executive at SUNESIS PHARMACEUTICALS INC (SNSS). They have executed 252 insider transactions totaling $107.3M over their tenure at the company.
Jonathan S. Leff holds the position of Executive at SUNESIS PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Jonathan S. Leff has shown a buying trading pattern, with $107.3M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Jonathan S. Leff was on May 13, 2011, when they sold $114.5M worth of ISPH shares. This transaction involved 22,907,488 shares at $5.00 per share.
Jonathan S. Leff currently owns 55,150 shares of SUNESIS PHARMACEUTICALS INC (SNSS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jonathan S. Leff's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jonathan S. Leff has 252 Form 4 filings on record as an insider at SUNESIS PHARMACEUTICALS INC.
Set alerts for Jonathan S. Leff and 40,000+ other insiders.